1 – 2 of 2
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2021
- 
                        Mark
        Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting
    
    - Contribution to journal › Article
 
- 1998
- 
                        Mark
        Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
    (1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307- Contribution to journal › Article